MedTrace Logo

Ventricular Reversed Remodeling After LTX in PAH Patients

NCT02391441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2019-08-26

No results posted yet for this study

Summary

The investigators will evaluate ventricular reversed remodelling after double lung transplantation (LTX) in patients with pulmonary arterial hypertension (PAH), measured with cardiac magnetic resonance imaging (MRI). Reversed remodelling will be compared with control patients without PAH (e.g. Cystic Fibrosis) who will also undergo LTX.

Conditions

Sponsors & Collaborators

  • Amsterdam UMC, location VUmc

    collaborator OTHER

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Dirk J van Veldhuisen, MD PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02391441 on ClinicalTrials.gov